Target intelligence / Profile preview

MexAB-OprM multidrug efflux pump complex (MexAB-OprM)

Target
MexAB-OprM
Molecular classification
Transporter, Multidrug efflux pump, Resistance-nodulation-cell division (RND) family pump
01

Overview

The MexAB-OprM multidrug efflux pump complex is a tripartite system in Pseudomonas aeruginosa, consisting of the inner membrane resistance-nodulation-division (RND) transporter MexB, the periplasmic membrane fusion protein MexA, and the outer membrane channel OprM. It spans the inner and outer membranes, using proton motive force to actively export a broad range of substrates from the cytoplasm and periplasm to the extracellular space, including structurally diverse antibiotics (e.g., β-lactams, fluoroquinolones, macrolides), detergents, dyes, organic solvents, quorum sensing molecules, and possibly virulence factors. MexB forms a trimeric pump that recognizes and captures substrates via vestibules and a central cavity, MexA oligomerizes to bridge MexB and OprM, and OprM provides a β-barrel channel open to the exterior. This pump is constitutively expressed at basal levels but upregulated via regulators like CpxR (binding the distal promoter) and mutations in repressors (e.g., MexR, NalD), contributing to intrinsic and acquired multidrug resistance in clinical isolates. Overexpression, particularly in nalB-type strains, reduces intracellular antibiotic accumulation, enabling resistance to multiple drugs and complicating treatment of P. aeruginosa infections such as pneumonia, sepsis, urinary tract infections, and chronic cystic fibrosis cases. Structural studies (e.g., cryo-EM) reveal its assembly and peristaltic mechanism for substrate translocation, informing efflux pump inhibitor development to restore antibiotic efficacy.

Other names
MexAB-OprM efflux pumpMexAB-OprM pump
02

Mechanism of action

Efflux pump inhibition (targeting assembly or function to block drug export and restore antibiotic susceptibility)

03

Biological functions

Multidrug effluxExport of antimicrobialsExport of quorum sensing molecules (homoserine lactones)Export of virulence factorsRemoval of metabolic by-products (e.g., oxidized fatty acids)
04

Disease associations

InfectionMultidrug resistance in bacterial infections (Pseudomonas aeruginosa)
05

Safety considerations

Overexpression leads to multidrug resistance in clinical Pseudomonas aeruginosa isolates (e.g., nalB-type strains), complicating treatment of nosocomial infections, pneumonia, sepsis, cystic fibrosis
06

Interacting drugs

β-lactams

11 more in the full profile.

Beyond the preview

Go deeper on MexAB-OprM multidrug efflux pump complex (MexAB-OprM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MexAB-OprM multidrug efflux pump complex (MexAB-OprM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call